183 related articles for article (PubMed ID: 29427433)
1. Highly sensitive detection of mutations in CHO cell recombinant DNA using multi-parallel single molecule real-time DNA sequencing.
Cartwright JF; Anderson K; Longworth J; Lobb P; James DC
Biotechnol Bioeng; 2018 Jun; 115(6):1485-1498. PubMed ID: 29427433
[TBL] [Abstract][Full Text] [Related]
2. Identifying low-level sequence variants via next generation sequencing to aid stable CHO cell line screening.
Zhang S; Bartkowiak L; Nabiswa B; Mishra P; Fann J; Ouellette D; Correia I; Regier D; Liu J
Biotechnol Prog; 2015; 31(4):1077-85. PubMed ID: 26033952
[TBL] [Abstract][Full Text] [Related]
3. Targeted single molecule sequencing methodology for ovarian hyperstimulation syndrome.
Orkunoglu-Suer F; Harralson AF; Frankfurter D; Gindoff P; O'Brien TJ
BMC Genomics; 2015 Apr; 16(1):264. PubMed ID: 25888426
[TBL] [Abstract][Full Text] [Related]
4. Enhanced CHO Clone Screening: Application of Targeted Locus Amplification and Next-Generation Sequencing Technologies for Cell Line Development.
Aeschlimann SH; Graf C; Mayilo D; Lindecker H; Urda L; Kappes N; Burr AL; Simonis M; Splinter E; van Min M; Laux H
Biotechnol J; 2019 Jul; 14(7):e1800371. PubMed ID: 30793505
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells.
Merrihew RV; Clay WC; Condreay JP; Witherspoon SM; Dallas WS; Kost TA
J Virol; 2001 Jan; 75(2):903-9. PubMed ID: 11134303
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutation analysis at early stages of cell line development using next generation sequencing.
Wright C; Groot J; Swahn S; McLaughlin H; Liu M; Xu C; Sun C; Zheng E; Estes S
Biotechnol Prog; 2016 May; 32(3):813-7. PubMed ID: 27004436
[TBL] [Abstract][Full Text] [Related]
7. Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35.
Zhao M; Wang J; Luo M; Luo H; Zhao M; Han L; Zhang M; Yang H; Xie Y; Jiang H; Feng L; Lu H; Zhu J
Appl Microbiol Biotechnol; 2018 Jul; 102(14):6105-6117. PubMed ID: 29789882
[TBL] [Abstract][Full Text] [Related]
8. Early identification of unusually clustered mutations and root causes in therapeutic antibody development.
Qian Y; Chen Z; Huang X; Wang X; Xu X; Kirov S; Ludwig R; Qian NX; Ravi K; Tao L; Borys MC; Li ZJ
Biotechnol Bioeng; 2018 Sep; 115(9):2377-2382. PubMed ID: 29777592
[TBL] [Abstract][Full Text] [Related]
9. Calcium phosphate transfection generates mammalian recombinant cell lines with higher specific productivity than polyfection.
Chenuet S; Martinet D; Besuchet-Schmutz N; Wicht M; Jaccard N; Bon AC; Derouazi M; Hacker DL; Beckmann JS; Wurm FM
Biotechnol Bioeng; 2008 Dec; 101(5):937-45. PubMed ID: 18781700
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel endogenous regulatory element in Chinese hamster ovary cells by promoter trap.
Chen J; Haverty J; Deng L; Li G; Qiu P; Liu Z; Shi S
J Biotechnol; 2013 Sep; 167(3):255-61. PubMed ID: 23850860
[TBL] [Abstract][Full Text] [Related]
11. A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment.
Rajendra Y; Hougland MD; Alam R; Morehead TA; Barnard GC
Biotechnol Bioeng; 2015 May; 112(5):977-86. PubMed ID: 25502369
[TBL] [Abstract][Full Text] [Related]
12. Epi-CHO, an episomal expression system for recombinant protein production in CHO cells.
Kunaparaju R; Liao M; Sunstrom NA
Biotechnol Bioeng; 2005 Sep; 91(6):670-7. PubMed ID: 15948170
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterization of CHO production host DG44 and derivative recombinant cell lines.
Derouazi M; Martinet D; Besuchet Schmutz N; Flaction R; Wicht M; Bertschinger M; Hacker DL; Beckmann JS; Wurm FM
Biochem Biophys Res Commun; 2006 Feb; 340(4):1069-77. PubMed ID: 16403443
[TBL] [Abstract][Full Text] [Related]
14. Sequencing the CHO DXB11 genome reveals regional variations in genomic stability and haploidy.
Kaas CS; Kristensen C; Betenbaugh MJ; Andersen MR
BMC Genomics; 2015 Mar; 16(1):160. PubMed ID: 25887056
[TBL] [Abstract][Full Text] [Related]
15. Generation of recombinant Chinese hamster ovary cell lines by microinjection.
Derouazi M; Flaction R; Girard P; de Jesus M; Jordan M; Wurm FM
Biotechnol Lett; 2006 Mar; 28(6):373-82. PubMed ID: 16614902
[TBL] [Abstract][Full Text] [Related]
16. Analytical assessment of clonal derivation of eukaryotic/CHO cell populations.
Aebischer-Gumy C; Moretti P; Little TA; Bertschinger M
J Biotechnol; 2018 Nov; 286():17-26. PubMed ID: 30172783
[TBL] [Abstract][Full Text] [Related]
17. Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system.
Zhou H; Liu ZG; Sun ZW; Huang Y; Yu WY
J Biotechnol; 2010 May; 147(2):122-9. PubMed ID: 20371256
[TBL] [Abstract][Full Text] [Related]
18. SMRT Gate: A method for validation of synthetic constructs on Pacific Biosciences sequencing platforms.
D'Amore R; Johnson J; Haldenby S; Hall N; Hughes M; Joynson R; Kenny JG; Patron N; Hertz-Fowler C; Hall A
Biotechniques; 2017 Jul; 63(1):13-20. PubMed ID: 28701143
[TBL] [Abstract][Full Text] [Related]
19. Plasmid integration, amplification and cytogenetics in CHO cells: questions and comments.
Wurm FM; Petropoulos CJ
Biologicals; 1994 Jun; 22(2):95-102. PubMed ID: 7917238
[TBL] [Abstract][Full Text] [Related]
20. Ensuring the consistency of rDNA-derived biologicals: the contribution of gene sequencing.
Griffiths E
Dev Biol Stand; 1994; 83():179-82. PubMed ID: 7883093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
